King Charles celebrates milestone birthday as Palace unveils regal portrait and sweet tribute - A new portrait of the King ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression aft ...

Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 monthsBiomarker analysis confirms immune activatio ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...

Royal expert and historian Richard Fitzwilliams believes it is "unlikely" that the Duke of Sussex will appear at this ...

With virtually no food allowed into the northernmost part of Gaza for the past month, tens of thousands of Palestinians under Israeli siege are rationing their last lentils and flour to survive. As ...

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 ...

TEVIMBRA ® (tislelizumab)is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1 ...